There is limited experience with single doses higher than 400 mg/m2 body surface area to date or weekly administrations of doses higher than 250 mg/m2 body surface area. In clinical studies with doses up to 700 mg/m2 given every 2 weeks the safety profile was consistent with that described in Adverse Reactions.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
